Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 774-775 [2024-00050]

Download as PDF 774 Federal Register / Vol. 89, No. 4 / Friday, January 5, 2024 / Notices This action deletes product(s) from the Procurement List that were furnished by nonprofit agencies employing persons who are blind or have other severe disabilities. DATES: Date deleted from the Procurement List: February 4, 2024. ADDRESSES: Committee for Purchase From People Who Are Blind or Severely Disabled, 355 E Street SW, Suite 325, Washington, DC 20024. FOR FURTHER INFORMATION CONTACT: Michael R. Jurkowski, Telephone: (703) 785–6404 or email CMTEFedReg@ AbilityOne.gov. SUMMARY: SUPPLEMENTARY INFORMATION: Deletions On 12/1/2023, the Committee for Purchase From People Who Are Blind or Severely Disabled published notice of proposed deletions from the Procurement List. This notice is published pursuant to 41 U.S.C. 8503(a)(2) and 41 CFR 51–2.3. After consideration of the relevant matter presented, the Committee has determined that the product(s) listed below are no longer suitable for procurement by the Federal Government under 41 U.S.C. 8501–8506 and 41 CFR 51–2.4. Regulatory Flexibility Act Certification I certify that the following action will not have a significant impact on a substantial number of small entities. The major factors considered for this certification were: 1. The action will not result in additional reporting, recordkeeping or other compliance requirements for small entities. 2. The action may result in authorizing small entities to furnish the product(s) to the Government. 3. There are no known regulatory alternatives which would accomplish the objectives of the Javits-WagnerO’Day Act (41 U.S.C. 8501–8506) in connection with the product(s) deleted from the Procurement List. End of Certification lotter on DSK11XQN23PROD with NOTICES1 Accordingly, the following product(s) are deleted from the Procurement List: Product(s) NSN(s)—Product Name(s): 7520–01–682–7166—Pen, Ballpoint, Stick, Recycled Water Bottle, Blue, Fine Point Designated Source of Supply: West Texas Lighthouse for the Blind, San Angelo, TX Contracting Activity: GSA/FAS ADMIN SVCS ACQUISITION BR(2, NEW YORK, NY NSN(s)—Product Name(s): 6840–01–367–2914—Detergent, Disinfectant, Water Soluble, .5 oz VerDate Sep<11>2014 17:32 Jan 04, 2024 Jkt 262001 Designated Source of Supply: Goodwill Vision Enterprises, Rochester, NY Contracting Activity: GSA/FSS GREATER SOUTHWEST ACQUISITI, FORT WORTH, TX NSN(s)—Product Name(s): 7530–00–NIB–0420—Jacket No. 605–913 Designated Source of Supply: CLOVERNOOK CENTER FOR THE BLIND AND VISUALLY IMPAIRED, Cincinnati, OH Contracting Activity: Government Printing Office, Washington, DC NSN(s)—Product Name(s): 1560–00–875–6001—Support, Structural Designated Source of Supply: The Lighthouse for the Blind, Inc. (Seattle Lighthouse), Seattle, WA Contracting Activity: DLA AVIATION, RICHMOND, VA NSN(s)—Product Name(s): 6645–01–491–9838—Clock, Wall, Atomic, Mahogany Octagon, 12″ Diameter 6645–01–491–9839—Clock, Wall, Atomic, Mahogany Octagon, Custom Logo, 12″ Diameter Designated Source of Supply: Chicago Lighthouse Industries, Chicago, IL Contracting Activity: GSA/FAS ADMIN SVCS ACQUISITION BR(2, NEW YORK, NY NSN(s)—Product Name(s): 3990–00–NSH–0081—Sideboard Pallet, 48″ x 48″ Designated Source of Supply: Knox County Association for Remarkable Citizens, Inc., Vincennes, IN Contracting Activity: W39Z STK REC ACCT– CRANE AAP, CRANE, IN NSN(s)—Product Name(s): 8970–00–NSH–0026—Meal Kit, Turkey, Detainees, DHS ICE 8970–00–NSH–0027—Meal Kit, Roast Beef, Detainees, DHS ICE Designated Source of Supply: The Arc of Cumberland and Perry Counties, Carlisle, PA Contracting Activity: COMPLIANCE&REMOVALS, WASHINGTON, DC Michael R. Jurkowski, Acting Director, Business Operations. [FR Doc. 2024–00023 Filed 1–4–24; 8:45 am] BILLING CODE 6353–01–P COMMODITY FUTURES TRADING COMMISSION Sunshine Act Meetings 9:00 a.m. EST, Friday, January 12, 2024. PLACE: Virtual meeting. STATUS: Closed. MATTERS TO BE CONSIDERED: Enforcement matters. In the event that the time, date, or location of this meeting changes, an announcement of the change, along with the new time, date, and/or place of the meeting will be posted on the Commission’s website at https://www.cftc.gov/. TIME AND DATE: PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 CONTACT PERSON FOR MORE INFORMATION: Christopher Kirkpatrick, 202–418–5964. Authority: 5 U.S.C. 552b. Dated: January 3, 2024. Robert Sidman, Deputy Secretary of the Commission. [FR Doc. 2024–00144 Filed 1–3–24; 4:15 pm] BILLING CODE 6351–01–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) will take place. DATES: Open to the public Wednesday, January 3, 2024, 10:00 a.m. to 1:00 p.m. (Eastern Standard Time). ADDRESSES: The meeting will be held telephonically or via conference call. The phone number for the remote access on January 3, 2024, is: CONUS: 1–800– 369–2046; OCONUS: 1–203–827–7030; PARTICIPANT CODE: 8546285. These numbers and the dial-in instructions will also be posted on the UFBAP website at: https:// www.health.mil/Military-Health-Topics/ Access-Cost-Quality-and-Safety/ Pharmacy-Operations/BAP. FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) Colonel Paul B. Carby, USA, 703–681– 2890 (voice), dha.ncr.j6.mbx.baprequests@health.mil (email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https:// www.health.mil/Military-Health-Topics/ Access-Cost-Quality-and-Safety/ Pharmacy-Operations/BAP. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of the Designated Federal Officer, the Uniform Formulary Beneficiary Advisory Panel was unable to provide public notification required by 41 CFR 102– 3.150(a) concerning its January 3, 2024 meeting. Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 SUMMARY: E:\FR\FM\05JAN1.SGM 05JAN1 lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 89, No. 4 / Friday, January 5, 2024 / Notices CFR 102–3.150(b), waives the 15calendar day notification requirement. This meeting is being held under the provisions of 5 United States Code (U.S.C.) chapter 10 (commonly known as the Federal Advisory Committee Act or FACA), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. Purpose of the Meeting: The UFBAP will review and comment on recommendations made by the Pharmacy and Therapeutics Committee to the Director, Defense Health Agency regarding the Uniform Formulary. Agenda: 1. 10:00 a.m. Sign In for UFBAP members 2. 10:10 a.m.–10:40 a.m. Welcome and Opening Remarks a. Welcome, Opening Remarks, and Introduction of UFBAP Members by COL Paul B. Carby, DFO, UFBAP b. Public Written Comments by COL Paul B. Carby, DFO, UFBAP c. Opening Remarks by Mr. Jon Ostrowski, UFBAP Chair d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary Management Branch 3. 10:40 a.m.–11:45 a.m. Scheduled Therapeutic Class Reviews 4. 11:45 a.m.–12:30 p.m. Newly Approved Drugs Review 5. 12:30 p.m.–12:45 p.m. Pertinent Utilization Management Issues 6. 12:45 p.m.–1:00 p.m. Closing remarks a. Closing Remarks by UFBAP CoChair b. Closing Remarks by DFO, UFBAP Meeting Accessibility: Pursuant to section 1009(a)(1) of the FACA and 41 CFR 102–3.140 through 102–3.165, and subject to the availability of phone lines, this meeting is open to the public. Telephone lines are limited and available to the first 220 people dialing in. There will be 220 lines total: 200 domestic and 20 international, including leader lines. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140(c), and section 1009(a)(3) of title 5, U.S.C., interested persons or organizations may submit written statements to the UFBAP about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the UFBAP’s DFO. The DFO’s contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or statements must be received by the UFBAP’s DFO no later than 8:00 a.m. EST, Wednesday, January 3, 2024, so they may be made available to the UFBAP for its consideration prior to the VerDate Sep<11>2014 17:32 Jan 04, 2024 Jkt 262001 meeting. Written comments received are releasable to the public. The DFO will review all submitted written statements and provide copies to UFBAP. Dated: January 2, 2024. Natalie M. Ragland, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2024–00050 Filed 1–2–24; 4:15 pm] BILLING CODE 6001–FR–P DEPARTMENT OF EDUCATION [Docket No.: ED–2023–SCC–0184] Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Application for the Educational Flexibility (Ed-Flex) Program Office of Elementary and Secondary Education (OESE), Department of Education (ED). ACTION: Notice. AGENCY: In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing a revision of a currently approved information collection request (ICR). DATES: Interested persons are invited to submit comments on or before February 5, 2024. ADDRESSES: Written comments and recommendations for proposed information collection requests should be submitted within 30 days of publication of this notice. Click on this link www.reginfo.gov/public/do/ PRAMain to access the site. Find this information collection request (ICR) by selecting ‘‘Department of Education’’ under ‘‘Currently Under Review,’’ then check the ‘‘Only Show ICR for Public Comment’’ checkbox. Reginfo.gov provides two links to view documents related to this information collection request. Information collection forms and instructions may be found by clicking on the ‘‘View Information Collection (IC) List’’ link. Supporting statements and other supporting documentation may be found by clicking on the ‘‘View Supporting Statement and Other Documents’’ link. FOR FURTHER INFORMATION CONTACT: For specific questions related to collection activities, please contact Even Skloot, 202–453–6515. SUPPLEMENTARY INFORMATION: The Department is especially interested in public comment addressing the following issues: (1) is this collection necessary to the proper functions of the Department; (2) will this information be SUMMARY: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 775 processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the Department enhance the quality, utility, and clarity of the information to be collected; and (5) how might the Department minimize the burden of this collection on the respondents, including through the use of information technology. Please note that written comments received in response to this notice will be considered public records. Title of Collection: Application for the Educational Flexibility (Ed-Flex) Program. OMB Control Number: 1810–0737. Type of Review: A revision of a currently approved ICR. Respondents/Affected Public: State, Local, and Tribal Governments. Total Estimated Number of Annual Responses: 32. Total Estimated Number of Annual Burden Hours: 620. Abstract: This is a request for a revision to the Educational Flexibility program application to include the annual reporting template. The Educational Flexibility (Ed-Flex) program is authorized under the Education Flexibility Partnership Act of 1999 and was reauthorized by section 9207 of the Every Student Succeeds Act (ESSA). The Ed-Flex program allows the Secretary to authorize a State educational agency (SEA) that serves an eligible State to waive statutory or regulatory requirements applicable to one or more the included programs for any local educational agency (LEAs), educational service agency, or school within the State. Section 4(a)(3) of the Education Flexibility Partnership Act of 1999 requires each SEA desiring to participate in the education flexibility program to submit an application detailing that SEAs education flexibility plan. Section 4(a)(5)(B) requires each SEA that is authorized to become an EdFlex Partnership State to submit an annual report on the results of its oversight and the impact of the waivers on school and student performance. Previously, the annual reporting requirement instructions and burden hours were included as part of the application. In order to standardize reporting, we have created an annual reporting template and are increasing the burden hours related to the annual reporting based on feedback from the field. However, overall, there is a decrease in burden due to a change in the estimated number of responses based on past experience with the program. E:\FR\FM\05JAN1.SGM 05JAN1

Agencies

[Federal Register Volume 89, Number 4 (Friday, January 5, 2024)]
[Notices]
[Pages 774-775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00050]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce that the 
following Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (UFBAP) will take place.

DATES: Open to the public Wednesday, January 3, 2024, 10:00 a.m. to 
1:00 p.m. (Eastern Standard Time).

ADDRESSES: The meeting will be held telephonically or via conference 
call. The phone number for the remote access on January 3, 2024, is: 
CONUS: 1-800-369-2046; OCONUS: 1-203-827-7030; PARTICIPANT CODE: 
8546285.
    These numbers and the dial-in instructions will also be posted on 
the UFBAP website at: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP.

FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) 
Colonel Paul B. Carby, USA, 703-681-2890 (voice), [email protected] (email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP. The most up-to-date changes to the meeting 
agenda can be found on the website.

SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of 
the Designated Federal Officer, the Uniform Formulary Beneficiary 
Advisory Panel was unable to provide public notification required by 41 
CFR 102-3.150(a) concerning its January 3, 2024 meeting. Accordingly, 
the Advisory Committee Management Officer for the Department of 
Defense, pursuant to 41

[[Page 775]]

CFR 102-3.150(b), waives the 15-calendar day notification requirement.
    This meeting is being held under the provisions of 5 United States 
Code (U.S.C.) chapter 10 (commonly known as the Federal Advisory 
Committee Act or FACA), the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
    Purpose of the Meeting: The UFBAP will review and comment on 
recommendations made by the Pharmacy and Therapeutics Committee to the 
Director, Defense Health Agency regarding the Uniform Formulary.
    Agenda:

1. 10:00 a.m. Sign In for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
    a. Welcome, Opening Remarks, and Introduction of UFBAP Members by 
COL Paul B. Carby, DFO, UFBAP
    b. Public Written Comments by COL Paul B. Carby, DFO, UFBAP
    c. Opening Remarks by Mr. Jon Ostrowski, UFBAP Chair
    d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary 
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
    a. Closing Remarks by UFBAP Co-Chair
    b. Closing Remarks by DFO, UFBAP

    Meeting Accessibility: Pursuant to section 1009(a)(1) of the FACA 
and 41 CFR 102-3.140 through 102-3.165, and subject to the availability 
of phone lines, this meeting is open to the public. Telephone lines are 
limited and available to the first 220 people dialing in. There will be 
220 lines total: 200 domestic and 20 international, including leader 
lines.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and section 1009(a)(3) of title 5, U.S.C., interested persons 
or organizations may submit written statements to the UFBAP about its 
mission and/or the agenda to be addressed in this public meeting. 
Written statements should be submitted to the UFBAP's DFO. The DFO's 
contact information can be found in the FOR FURTHER INFORMATION CONTACT 
section of this notice. Written comments or statements must be received 
by the UFBAP's DFO no later than 8:00 a.m. EST, Wednesday, January 3, 
2024, so they may be made available to the UFBAP for its consideration 
prior to the meeting. Written comments received are releasable to the 
public. The DFO will review all submitted written statements and 
provide copies to UFBAP.

    Dated: January 2, 2024.
Natalie M. Ragland,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-00050 Filed 1-2-24; 4:15 pm]
BILLING CODE 6001-FR-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.